Global Compounding Pharmacy Market Size was estimated at USD 11582.73 million in 2022 and is projected to reach USD 13983.9 million by 2028, exhibiting a CAGR of 2.73% during the forecast period.
Global Compounding Pharmacy Market Overview:
Global Compounding Pharmacy Market Report 2022 comes with the extensive industry analysis with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2022-2028.This research study of Compounding Pharmacy involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Compounding Pharmacy Market
The Compounding Pharmacy Market Research report incorporate value chain analysis for each of the product type. Value chain analysis offers in depth information about value addition at each stage.The study includes drivers and restraints for Compounding Pharmacy Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Compounding Pharmacy Market helps user to make precise decision in order to expand their market presence and increase market share.
Impact of COVID-19 on Compounding Pharmacy Market
Report covers Impact of Coronavirus COVID-19: Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost every country around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Compounding Pharmacy market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor/outdoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
Global Compounding Pharmacy Market Segmentation
Global Compounding Pharmacy Market Research report comprises of Porter's five forces analysis to do the detail study about its each segmentation like Product segmentation, End user/application segment analysis and Major key players analysis mentioned as below;
By Type, Compounding Pharmacy market has been segmented into:
PIA
PAA
CUPM
PDA
SAPM
By Application, Compounding Pharmacy market has been segmented into:
Consumers Aged 18 and Younger
Consumers Aged 19 to 44
Consumers Aged 45 to 64
Consumers Aged 65 and Older
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Compounding Pharmacy market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Compounding Pharmacy market.
Top Key Players Covered in Compounding Pharmacy market are:
PharMEDium Services
B. Braun Group
Fagron
Wedgewood Pharmacy
New Compounding Pharma
Medisca
Fresenius Kabi
Advanced Pharma
AIN GROUP
Nihon Chouzai
Sogo Medical
Dougherty's Pharmacy
Apollo Pharmacy
Downing Labs
Qol Holdings
Olympia Pharmacy
PUMCH
Triangle Compounding Pharmacy
Peking University First Hospital
Affiliated Hospital of Guangdong Public Institution of Medicine
Lorraine's Pharmacy
PLAGH
Institutional Pharmacy Solutions
Ruijin Hospital
Belle Sante
Byculla PharmacyandStores
Royal Chemists
Village Compounding Pharmacy
Specialist Pharmacy
Objective to buy this Report:
1. Compounding Pharmacy analysis predicts the representation of this market, supply and demand, capacity, detailed investigations, etc.
2. Even the report, along with the international series, conducts an in-depth study of rules, policies and current policy.
3. In addition, additional factors are mentioned: imports, arrangement of commodity prices for the market, supply and demand of industry products, major manufacturers.
4. The report starts with Compounding Pharmacy market statistics and moves to important points, with dependent markets categorized by market trend by application.
5. Applications of market may also be assessed based on their performances.
6. Other market attributes, such as future aspects, limitations and growth for all departments.
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Compounding Pharmacy Market by Type
5.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
5.2 Compounding Pharmacy Market Overview
5.3 PIA
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2016-2028F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 PIA: Geographic Segmentation
5.4 PAA
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2016-2028F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 PAA: Geographic Segmentation
5.5 CUPM
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2016-2028F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 CUPM: Geographic Segmentation
5.6 PDA
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2016-2028F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 PDA: Geographic Segmentation
5.7 SAPM
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2016-2028F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 SAPM: Geographic Segmentation
Chapter 6: Compounding Pharmacy Market by Application
6.1 Compounding Pharmacy Market Overview Snapshot and Growth Engine
6.2 Compounding Pharmacy Market Overview
6.3 Consumers Aged 18 and Younger
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2016-2028F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Consumers Aged 18 and Younger: Geographic Segmentation
6.4 Consumers Aged 19 to 44
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2016-2028F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Consumers Aged 19 to 44: Geographic Segmentation
6.5 Consumers Aged 45 to 64
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2016-2028F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Consumers Aged 45 to 64: Geographic Segmentation
6.6 Consumers Aged 65 and Older
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2016-2028F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Consumers Aged 65 and Older: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Compounding Pharmacy Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Compounding Pharmacy Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Compounding Pharmacy Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PHARMEDIUM SERVICES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 B. BRAUN GROUP
7.4 FAGRON
7.5 WEDGEWOOD PHARMACY
7.6 NEW COMPOUNDING PHARMA
7.7 MEDISCA
7.8 FRESENIUS KABI
7.9 ADVANCED PHARMA
7.10 AIN GROUP
7.11 NIHON CHOUZAI
7.12 SOGO MEDICAL
7.13 DOUGHERTY'S PHARMACY
7.14 APOLLO PHARMACY
7.15 DOWNING LABS
7.16 QOL HOLDINGS
7.17 OLYMPIA PHARMACY
7.18 PUMCH
7.19 TRIANGLE COMPOUNDING PHARMACY
7.20 PEKING UNIVERSITY FIRST HOSPITAL
7.21 AFFILIATED HOSPITAL OF GUANGDONG PUBLIC INSTITUTION OF MEDICINE
7.22 LORRAINE'S PHARMACY
7.23 PLAGH
7.24 INSTITUTIONAL PHARMACY SOLUTIONS
7.25 RUIJIN HOSPITAL
7.26 BELLE SANTE
7.27 BYCULLA PHARMACYANDSTORES
7.28 ROYAL CHEMISTS
7.29 VILLAGE COMPOUNDING PHARMACY
7.30 SPECIALIST PHARMACY
Chapter 8: Global Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 PIA
8.2.2 PAA
8.2.3 CUPM
8.2.4 PDA
8.2.5 SAPM
8.3 Historic and Forecasted Market Size By Application
8.3.1 Consumers Aged 18 and Younger
8.3.2 Consumers Aged 19 to 44
8.3.3 Consumers Aged 45 to 64
8.3.4 Consumers Aged 65 and Older
Chapter 9: North America Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 PIA
9.4.2 PAA
9.4.3 CUPM
9.4.4 PDA
9.4.5 SAPM
9.5 Historic and Forecasted Market Size By Application
9.5.1 Consumers Aged 18 and Younger
9.5.2 Consumers Aged 19 to 44
9.5.3 Consumers Aged 45 to 64
9.5.4 Consumers Aged 65 and Older
9.6 Historic and Forecast Market Size by Country
9.6.1 U.S.
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Europe Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 PIA
10.4.2 PAA
10.4.3 CUPM
10.4.4 PDA
10.4.5 SAPM
10.5 Historic and Forecasted Market Size By Application
10.5.1 Consumers Aged 18 and Younger
10.5.2 Consumers Aged 19 to 44
10.5.3 Consumers Aged 45 to 64
10.5.4 Consumers Aged 65 and Older
10.6 Historic and Forecast Market Size by Country
10.6.1 Germany
10.6.2 U.K.
10.6.3 France
10.6.4 Italy
10.6.5 Russia
10.6.6 Spain
10.6.7 Rest of Europe
Chapter 11: Asia-Pacific Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 PIA
11.4.2 PAA
11.4.3 CUPM
11.4.4 PDA
11.4.5 SAPM
11.5 Historic and Forecasted Market Size By Application
11.5.1 Consumers Aged 18 and Younger
11.5.2 Consumers Aged 19 to 44
11.5.3 Consumers Aged 45 to 64
11.5.4 Consumers Aged 65 and Older
11.6 Historic and Forecast Market Size by Country
11.6.1 China
11.6.2 India
11.6.3 Japan
11.6.4 Singapore
11.6.5 Australia
11.6.6 New Zealand
11.6.7 Rest of APAC
Chapter 12: Middle East & Africa Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 PIA
12.4.2 PAA
12.4.3 CUPM
12.4.4 PDA
12.4.5 SAPM
12.5 Historic and Forecasted Market Size By Application
12.5.1 Consumers Aged 18 and Younger
12.5.2 Consumers Aged 19 to 44
12.5.3 Consumers Aged 45 to 64
12.5.4 Consumers Aged 65 and Older
12.6 Historic and Forecast Market Size by Country
12.6.1 Turkey
12.6.2 Saudi Arabia
12.6.3 Iran
12.6.4 UAE
12.6.5 Africa
12.6.6 Rest of MEA
Chapter 13: South America Compounding Pharmacy Market Analysis, Insights and Forecast, 2016-2028
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 PIA
13.4.2 PAA
13.4.3 CUPM
13.4.4 PDA
13.4.5 SAPM
13.5 Historic and Forecasted Market Size By Application
13.5.1 Consumers Aged 18 and Younger
13.5.2 Consumers Aged 19 to 44
13.5.3 Consumers Aged 45 to 64
13.5.4 Consumers Aged 65 and Older
13.6 Historic and Forecast Market Size by Country
13.6.1 Brazil
13.6.2 Argentina
13.6.3 Rest of SA
Chapter 14 Investment Analysis
Chapter 15 Analyst Viewpoint and Conclusion
Publisher: Introspective Market Research
Related Reports
- Biosimilars Market based on by Material Type (Silicon, Germanium, Transition Metal Oxides, Gold), Industry (Consumer Electronics, Automotive, Aviation, Energy, Medical Devices), Regional Outlook- Global Forecast up to 2032
- Vaccines Market by Type (Recombinant/Conjugate/Subunit, Inactivated, Live Attenuated and Toxoid), Route of Administration (Parenteral and Oral), Disease Indication and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
- Heart Failure Market by Type (Chronic Heart Failure, Acute Heart Failure), Therapeutic Drug, Distribution Channel, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
- Rosacea Treatment Market by Type (Erythematotelangiectatic Rosacea, Ocular Rosacea, Papulopustular Rosacea, Phymatous Rosacea), Drug Class, Mode of Administration, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
- Wearable Medical Devices Market by Product (Therapeutic Devices, Diagnostic Devices), Site (Handheld, Shoe Sensors, Headband, Strap/Clip/Bracelet), Application, Distribution Channel, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support
Frequently Asked Questions (FAQ)
Global Compounding Pharmacy Market Size was estimated at USD 11582.73 million in 2022 and is projected to reach USD 13983.9 million by 2028.
PharMEDium Services, B. Braun Group, Fagron, Wedgewood Pharmacy, New Compounding Pharma, Medisca, Fresenius Kabi, Advanced Pharma, AIN GROUP, Nihon Chouzai, Sogo Medical, Dougherty’s Pharmacy, Apollo Pharmacy, Downing Labs, Qol Holdings, Olympia Pharmacy, PUMCH, Triangle Compounding Pharmacy, Peking University First Hospital, Affiliated Hospital of Guangdong Public Institution of Medicine, Lorraines Pharmacy, PLAGH, Institutional Pharmacy Solutions, Ruijin Hospital, Belle Sante, Byculla PharmacyandStores, Royal Chemists, Village Compounding Pharmacy, Specialist Pharmacy
North America,Europe,Asia-Pacific,South America,Middle East & Africa